General Information of the Compound
Compound ID
CP0041026
Compound Name
(2S)-2-[(5-{methyl[(2-methyl-4-oxo-1,4-dihydroquinazolin-6-yl)methyl]amino}thiophen-2-yl)formamido]pentanedioic acid
    Show/Hide
Synonyms
(2S)-2-[[5-[methyl-[(2-methyl-4-oxo-1H-quinazolin-6-yl)methyl]amino]thiophene-2-carbonyl]amino]pentanedioic acid
112887-68-0
C21H22N4O6S
CHEBI:5847
CHEMBL225071
D 1694
D-1694
D1694
DSSTox_CID_26482
DSSTox_GSID_46482
DSSTox_RID_81653
FCB9EGG971
ICI D1694
ICI-D-1694
ICI-D1694
N-(5-(N-(3,4-Dihydro-2-methyl-4-oxoquinazolin-6-ylmethyl)-N-methylamino)-2-thenoyl)-L-glutamic acid
NCGC00229704-01
NSC-639186
Raltitrexed
Raltitrexed (Tomudex)
Tomudex
UNII-FCB9EGG971
ZD 1694
ZD-16
ZD-1694
ZD1694
    Show/Hide
Structure
Formula
C21H22N4O6S
Molecular Weight
458.496
Canonical SMILES
CN(Cc1ccc2nc(C)[nH]c(=O)c2c1)c1ccc(s1)C(=O)N[C@@H](CCC(O)=O)C(O)=O
    Show/Hide
InChI
InChI=1S/C21H22N4O6S/c1-11-22-14-4-3-12(9-13(14)19(28)23-11)10-25(2)17-7-6-16(32-17)20(29)24-15(21(30)31)5-8-18(26)27/h3-4,6-7,9,15H,5,8,10H2,1-2H3,(H,24,29)(H,26,27)(H,30,31)(H,22,23,28)/t15-/m0/s1
    Show/Hide
InChIKey
IVTVGDXNLFLDRM-HNNXBMFYSA-N
CAS
112887-68-0
Physicochemical Property
logP
1.97722
Rotatable Bonds
9
Heavy Atom Count
32
Polar Areas
152.69
Hydrogen Bond Donor Count
4
Hydrogen Bond Acceptor Count
7
Complexity
32

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 135400182
SID: 14906899
ChEMBL ID
CHEMBL225071
DrugBank ID
DB00293
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT04881, Folate receptor alpha
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000938 Chinese hamster RT16 Cricetulus griseus (Chinese hamster)  2
1
IC50 = 15 nM
   TI
   LI
   LO
   TS
2
IC50 > 1000 nM
   TI
   LI
   LO
   TS
Protein ID: PT06045, Folate receptor beta
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000344 D4 [Mouse hybridoma against human RICTOR] Mus musculus (Mouse)  2
1
IC50 = 22 nM
   TI
   LI
   LO
   TS
2
IC50 = 746 nM
   TI
   LI
   LO
   TS
Protein ID: PT05580, Proton-coupled folate transporter
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000937 R2/PCFT4 Cricetulus griseus (Chinese hamster)  1
1
IC50 = 99.5 nM
   TI
   LI
   LO
   TS
Protein ID: PT05723, Reduced folate transporter
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL001007 Chinese hamster PC43-10 Cricetulus griseus (Chinese hamster)  1
1
IC50 = 6.3 nM
   TI
   LI
   LO
   TS
Cell Viability or Cytotoxicity Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000220 KB Homo sapiens (Human)  2
1
IC50 = 5.9 nM
   TI
   LI
   LO
   TS
2
IC50 = 22 nM
   TI
   LI
   LO
   TS
CL000330 CHO Pro-4 MtxRII OuaR-2-4 Cricetulus griseus (Chinese hamster)  1
1
IC50 > 1000 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( Raltitrexed )
Drug Name Raltitrexed
Company AstraZeneca
Indication
Rectal adenocarcinoma
Approved